1st Quarter - Report — SOLVENTUM CORPORATION for SOLVENTUM CORPORATION (2018)

Firm

SOLVENTUM CORPORATION

Client

SOLVENTUM CORPORATION

Income

—

Expenses

$120,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, and value based purchasing Medicare and Medicaid data and patient-centered medical records policies Opioid epidemic related policies Implementation of the Patient Protection and Affordable Care Act (PL 111-148) Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255) Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10) Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10) S.428, ACE Kids Act H.R.3611, the Healthcare Outcomes Act H.R.3922 Champion Act S.1827, Kids' Insurance Dependable and Secure (KIDS)

Lobbyist	Covered position, as disclosed
MEGAN IVORY CARR	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 428 (115th), S. 1827 (115th), H.R. 3922 (115th), H.R. 3611 (115th)

Medicare/Medicaid MMM

Lobbyist	Covered position, as disclosed
MEGAN IVORY CARR	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 428 (115th), H.R. 3922 (115th), H.R. 3611 (115th), S. 1827 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.